Advertisement
Advertisement

PCVX

PCVX logo

Vaxcyte, Inc. Common Stock

58.42
USD
Sponsored
-1.41
-2.36%
Jul 10, 14:25 UTC -4
Open

PCVX Earnings Reports

Positive Surprise Ratio

PCVX beat 12 of 24 last estimates.

50%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$2.05
Implied change from Q1 26 (Revenue/ EPS)
--
/
-10.48%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+68.03%

Vaxcyte, Inc. Common Stock earnings per share and revenue

On May 06, 2026, PCVX reported earnings of -2.29 USD per share (EPS) for Q1 26, missing the estimate of -1.78 USD, resulting in a -28.74% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of -2.05 USD, with revenue projected to reach -- USD, implying an decrease of -10.48% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q1 2026, Vaxcyte, Inc. Common Stock reported EPS of -$2.29, missing estimates by -28.74%, and revenue of $0.00, 0% as expectations.
The stock price moved down -9.84%, changed from $57.10 before the earnings release to $51.48 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 7 analysts, Vaxcyte, Inc. Common Stock is expected to report EPS of -$2.05 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement